Can This High-Yield Dividend Stock Keep Beating the S&P 500?
Amgens shares have come under pressure this year, making it a compelling bargain buy.…
246,875€
-0,63%
Echtzeit-Aktienkurs Amgen Inc.
Bid:
Ask:
Nachrichten zur Amgen Inc. Aktie
Can This High-Yield Dividend Stock Keep Beating the S&P 500? @themotleyfool #stocks $AMGN
Amgens shares have come under pressure this year, making it a compelling bargain buy.…
Amgen: I Prefer To Chase Value And Dividends
…
Amgen: The Giant With An Impressive Pipeline
…
Is Amgen Stock a Buy? @themotleyfool #stocks $AMGN
Amgens stock isnt expensive, but the business does face some challenges, which could have investors thinking twice.…
Is Amgen Stock a Buy?
Amgens stock isnt expensive, but the business does face some challenges, which could have investors thinking twice.…
How to Invest in Biotechnology (Updated 2024)
Investors interested in the life science sector are well aware of the importance of biotechnology.From finding cures for diseases to…
Heres Why Amgen (AMGN) Stock is Outperforming the Industry
Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to make up for lower revenues from…
Amgen Aktie: Aussichten trotz Kursrückgang stabil
Amgen, der weltgrößte Biotechnologie-Medikamentenhersteller, sah im vergangenen Handelssitz einen leichten Aktienrückgang von 0,45%, der bei $283.04 schloss. Diese Performance lag…
Amgen-Aktie heute gut behauptet: Aktienwert steigt (263,7216 €)
Im Plus liegt aktuell die Amgen-Aktie . Das Wertpapier kostete zuletzt 285,36 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von…
Amgen-Aktien ohne Adipositas-Pipeline USD 240-USD 250 wert - Aktienanalyse
New York (www.aktiencheck.de) - Amgen-Aktienanalyse von J.P. Morgan Securities:
Die Analysten von J.P. Morgan Securities stufen die Aktie von Amgen Inc.…
Amgen wants in on the booming weight loss drug market — and its taking a different approach
Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after…
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note
In the closing of the recent trading day, Amgen (AMGN) stood at $271.73, denoting a +0.31% change from the preceding…
Eilt: Hautkrebs vollständig geheilt - Blockbuster-Potential. Neuer 797% Biotech Hot Stock nach 31.205% mit Amgen ($AMGN)
London (www.aktiencheck.de, Anzeige)
EinschätzungStrong OutperformerKurszieleKursziel 12M: 2,50 EUR
Kurschance: 541%
Kursziel 24M: 3,50 EUR
Kurschance: 797%StammdatenISIN: GB00BM9XQ619
WKN: A3DTUQ
Ticker: T9G.HMKursdatenKurs: 0,390 EUR
52W Hoch: 1,630 EUR
52W…
Amgen Will Benefit From Increased Medical Spending
…
5 Small Biotech ETFs to Watch (Updated 2024)
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…
Amgen declares $2.25 Q2 dividend for 2024 By Investing.com
Amgen declares $2.25 Q2 dividend for 2024…
Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)
…
Amgen: Rating erhöht
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Goldman Sachs stufen die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol:…
Amgen: A Good Dividend Growth Stock For The Watch List
…
Goldman adds Amgen, Monday.com, Vulcan to Conviction List By Investing.com
Goldman adds Amgen, Monday.com, Vulcan to Conviction List…
Amgen Aktie: Zukunftsträchtiger Ausblick
THOUSAND OAKS, Kalifornien - Amgen, ein Pionier in der Biotechnologie, hat entlang des letzten Jahres beeindruckende 24,3% an Aktienwert zugelegt…
Rare Disease Day 2024: Amgen stellt seltene Erkrankungen in den Fokus
München (ots) - Dieses Jahr fällt der Rare Disease Day auf den 29. Februar. Ein Tag, der den seltenen Erkrankungen…
Better Dividend Growth Stock: AbbVie or Amgen?
A strong case can be made for owning both of these dividend growth stocks. But one of them is the…
Better Dividend Growth Stock: AbbVie or Amgen? @themotleyfool #stocks $ABBV $AMGN $^GSPC
A strong case can be made for owning both of these dividend growth stocks. But one of them is the…
Top Research Reports for NVIDIA, Visa & Amgen
Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen…
Aktien USA: Dow Jones heute leicht im Plus (39.165 Pkt.)
Die Aktie von Amgen ist zur Stunde der größte Gewinner im Dow Jones-Index . Das Resultat Das Börsenbarometer klettert um…
Amgen Inc. (AMGN) Amgen Meeting on Rare Disease (Transcript)
…
If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today @themotleyfool #stocks $AMGN
Has Amgen been a market-beating stock?…
If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today
Has Amgen been a market-beating stock?…
Eilt: Big News voraus - Hautkrebs vollständig geheilt. Neuer 312% Biotech Hot Stock nach 31.205% mit Amgen ($AMGN)
London (www.aktiencheck.de, Anzeige)
EinschätzungStrong OutperformerKurszieleKursziel 12M: 2,50 EUR
Kurschance: 194%
Kursziel 24M: 3,50 EUR
Kurschance: 312%StammdatenISIN: GB00BM9XQ619
WKN: A3DTUQ
Ticker: T9G.HMKursdatenKurs: 0,850 EUR
52W Hoch: 1,630 EUR
52W…
Amgen Inc. (AMGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)
…
The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Amgen, Morphysys and REGENXBIO
Gilead Sciences, Bristol Myers, Amgen, Morphysys and REGENXBIO are included in this Analyst Blog.…
Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
…
ARWR: Pipeline Reprioritization to Reduce Cash Burn by up to $100 Million This Fiscal Year
By David Bautz, PhD
NASDAQ:ARWR
READ THE FULL ARWR RESEARCH REPORT
Business Update
Pipeline Reprioritization to Cut ~$100 Million in Expenses
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)…
Biotech Stock Roundup: GILD, AMGN & BMYs Q4 Results, MOR Up on NVS Deal & More
Earnings of Gilead (GILD) and Amgen (AMGN) are in focus in the biotech sector.…
Amgen steigert Quartalsgewinn - Kauf von Horizon zahlt sich aus
New York (Reuters) - Die milliardenschwere Übernahme des Biotechunternehmens Horizon Therapeutics zahlt sich für den US-Pharmakonzern Amgen aus.
Das US-Unternehmen steigerte…
Amgen quarterly profit rises 15%, obesity drug trials are on track By Reuters
© Reuters. The logo of Amgen and a robot miniature are seen in this illustration taken, July 17, 2023. REUTERS/Dado…
Amgen steigert Quartalsumsatz kräftig - Fortsetzung im laufenden Jahr erwartet
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hofft nach der Übernahme von Horizon Therapeutics auf einen kräftigen Umsatzanstieg im laufenden…
Amgen steigert Quartalsumsatz kräftig - Fortsetzung im laufenden Jahr erwartet
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hofft nach der Übernahme von Horizon Therapeutics auf…
Amgen’s quarterly results top expectations despite Enbrel sales decline
Amgen on Tuesday reported fourth quarter profits and sales that topped analyst expectations even as revenues dropped for one of…
Amgen Dips Despite A Record-Breaking Sales Sprint For Nine Drugs
Amgen beat sales and earnings estimates late Tuesday, helped by nine products that hit record sales.…
Amgen Q4 earnings and revenue beat estimates By Investing.com
Amgen Q4 earnings and revenue beat estimates…
Amgen earnings beat by $0.12, revenue topped estimates By Investing.com
Amgen earnings beat by $0.12, revenue topped estimates…
Amgen quarterly profit rises 15% as Horizon deal boosts results
…
Amgen quarterly profit rises 15% as Horizon deal boosts results By Reuters
Amgen quarterly profit rises 15% as Horizon deal boosts results…
DAX höher erwartet, China deutlich im Plus: Infineon, Morphosys, UBS, BP, Linde, Spotify, LVMH, Amgen, Qiagen und Ford im Fokus – das ist heute wichtig
Der DAX hat sich zu Wochenbeginn kaum verändert gezeigt. Letztendlich ging er mit 0,1 Prozent im Minus aus dem Handel…
Amgen’s obesity prospects in focus ahead of Q4 results
…
Merck, Walgreens and Amgen lead way as Dow’s intraday gain hits 200 points
…
Amgen: Debt-Funded Buybacks Constrains Future Gains Per Share
…